Clinical study demonstrates substantial respiratory syncytial virus burden in elderly and high-risk adults comparable to influenza A, highlighting the need for effective RSV vaccines.
RSV infection is an important illness in elderly and high-risk adults, with a disease burden similar to that of nonpandemic influenza A in a population in which the prevalence of vaccination for influenza is high. An effective RSV vaccine may offer benefits for these adults.
No takes yet. Share an insight, caveat, or question.
Falsey et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: